Mycoplasma pneumoniae infection prediction model for hospitalized community-acquired pneumonia children

Jiande Chen1, Yong Yin1,2,3, Liebin Zhao3

  • 1Department of Respiratory Medicine, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Pediatric Pulmonology
|September 21, 2021
PubMed

Insights

A new nomogram accurately predicts Mycoplasma pneumoniae (Mp) infection in hospitalized children with community-acquired pneumonia (CAP). This tool aids physicians in risk stratification and clinical decisions for pediatric CAP cases.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Medical Diagnostics

Background:

  • Community-acquired pneumonia (CAP) is a common pediatric illness.
  • Mycoplasma pneumoniae (Mp) is a frequent cause of CAP in children.
  • Accurate prediction of Mp infection aids in appropriate treatment and management.

Purpose of the Study:

  • To develop and validate a nomogram for predicting Mp infection in hospitalized children with CAP.
  • To compare the predictive performance of the nomogram with a simpler model based on age and fever duration.

Main Methods:

  • Retrospective analysis of 5904 hospitalized children with CAP.
  • Development of a nomogram using five predictors: age, fever duration, ESR, leukocyte count, and neutrophil proportion.
  • Validation of the nomogram using concordance index (C-index), Brier scores, and decision curve analysis (DCA).

Main Results:

  • The nomogram demonstrated good predictive accuracy with C-indices of 0.74 and 0.75 in training and validation sets.
  • Calibration plots showed moderate agreement between predicted and actual outcomes.
  • Decision curve analysis indicated good clinical utility, allowing risk stratification into low, medium, and high groups.

Conclusions:

  • A validated nomogram incorporating five clinical and laboratory variables effectively predicts Mp infection in pediatric CAP.
  • The nomogram serves as a valuable tool for clinical decision-making and risk assessment in pediatric infectious diseases.
  • The developed nomogram outperformed a simpler model based on age and fever duration.
Abstract

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
525
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
412
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
1.0K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.7K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
504